Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending March 18, 2022

Drug Industry TRx: -1.7% w/w

Vascepa
TRx 72,976; +2.8% (+1,976) w/w; -13.2% y/y
NRx 33,638; +1.3% (+416) w/w; -15.5% y/y
Ref 39,338; +4.1% (+1,560) w/w; -11.3% y/y

Lovaza (Generic & Brand)
TRx 63,372; -0.2% (-107) w/w; -0.1% y/y
NRx 33,089; -0.4% (-144) w/w; +3.7% y/y
Ref 30,283; -0.1% (+38) w/w; -4.0% y/y

Generic Vascepa
TRx 30,653; +0.1% (+44) w/w; As % of total V: 29.6%
NRx 17,076; -2.8% (-489) w/w; As % of total V: 33.7%
Ref 13,577; +4.1% (+534) w/w; As % of total V: 25.7%

Generic Vascepa by Manufacturer
Hikma - TRx 7,540 (-145); Generic share 24.6%; Total V share 7.3%
Reddy - TRx 14,111 (-208); Generic share 46.0%; Total V share 13.6%
Apotex - TRx 9,002 (+396); Generic share 29.4%; Total V share 8.7%

Vascepa + Generic Vascepa
TRx 103,629; +2.0% (+2,020) w/w; +10.4% y/y
NRx 50,714; -0.1% (-74) w/w; +11.2% y/y
Ref 52,915; +4.1% (+2,094) w/w; +9.6% y/y